Clinical Study | Office of Clinical Research

Ucci-Hn-19-02- Determining Hbd-3 As A Valid Biomarker In Head And Neck Cancer.

Posted Date: Oct 15, 2019

Investigator: Alice Tang
Specialties: Cancer, Head and Neck Cancer, Oncology
Type of Study: Observational/Survey

The goal of this study is to replicate the beta defensin index's ability to distinguish oral squamous cell carcinoma from non-cancerous lesions

Criteria:

To Be Eligible: 18 Years Or Older, Diagnosis Of Head And Neck Cancer, Any Condition Pi Finds To Be Confounding With Their Ability To Properly Participate In The Study

Keywords:

Head And Neck Cancer, Hnc, Oncology

For More Information:

Uccc Cancer Center
513-584-7698
cancer@uchealth.com

Name*
First Last
Gender*
- Male
- Female
Age*
Phone*
Email*
How did you hear about us?*
Future Communication*
- By submitting this form, I am agreeing to receive future communication about participating in an upcoming research study.
CAPTCHA
This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.
List